Bison Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,597
Closed -$355K 442
2024
Q3
$355K Buy
3,597
+857
+31% +$84.2K 0.06% 292
2024
Q2
$260K Hold
2,740
0.04% 351
2024
Q1
$260K Buy
2,740
+216
+9% +$20K 0.04% 351
2023
Q4
$225K Buy
+2,524
New +$187K 0.04% 362
2023
Q3
Sell
-2,466
Closed -$205K 410
2023
Q2
$205K Buy
+2,466
New +$206K 0.04% 355
2022
Q3
Sell
-31
Closed -$2K 372
2022
Q2
$2K Hold
31
﹤0.01% 315
2022
Q1
$3K Sell
31
-50
-62% -$4.62K ﹤0.01% 353
2021
Q4
$9K Sell
81
-4
-5% -$482 0.01% 313
2021
Q3
$11K Buy
85
+4
+5% +$515 0.01% 420
2021
Q2
$11K Hold
81
﹤0.01% 408
2021
Q1
$11K Sell
81
-50
-38% -$7.49K ﹤0.01% 419
2020
Q4
$18K Buy
131
+31
+31% +$3.97K 0.01% 332
2020
Q3
$11K Buy
100
+81
+426% +$9.08K 0.01% 317
2020
Q2
$2K Buy
+19
New +$1.87K ﹤0.01% 345

Other funds holding XBI

Bison Wealth's XBI Position: Q4 2024 in Review

Bison Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 3,597 shares — an estimated $355K sold.

Bison Wealth first reported a position in XBI in Q2 2020 and held it in 14 quarters. The position peaked at $355K in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Bison Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • Bison Wealth sold 3,597 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $355K.
  • Bison Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 14 quarters.
  • Bison Wealth's State Street SPDR S&P Biotech ETF position peaked at $355K in Q3 2024.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.